Tiblio
Sign Up

HOWL

Werewolf Therapeutics Inc
NASDAQHEALTHCAREBIOTECHNOLOGY

Key Statistics

Market Cap
$21.83M
P/E Ratio
—
EPS
$-1.23
Beta
0.30
52W High
$2.38
52W Low
$0.27
50-Day MA
$0.39
200-Day MA
$0.76
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—

About Werewolf Therapeutics Inc

Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapies designed to boost the body's immune system for the treatment of cancer. The company is headquartered in Cambridge, Massachusetts.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)0
Gross Profit (TTM)$-33.91M
EBITDA$-50.05M
Operating Margin0.00%
Return on Equity-161.90%
Return on Assets-39.10%
Revenue/Share (TTM)$0.00
Book Value$0.25
Price-to-Book1.76
Price-to-Sales (TTM)10.21
EV/Revenue0.674
EV/EBITDA0.57
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)-100.00%
Shares Outstanding$48.60M
Float$47.91M
% Insiders1.40%
% Institutions26.70%

Historical Volatility

HV 10-Day
95.45%
HV 20-Day
117.17%
HV 30-Day
110.16%
HV 60-Day
99.43%
HV Rank
—

Volatility is currently contracting

Analyst Ratings

Consensus ($7.00 target)
2
Buy

Latest News

Werewolf Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Updates

WATERTOWN, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions, today provided a business update and reported financial results for the first quarter ended March 31, 2026.

GlobeNewsWire5/7/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on HOWL and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

LLYEli Lilly and CompanyJNJJohnson & JohnsonABBVAbbVie IncUNHUnitedHealth Group IncorporatedMRKMerck & Company IncNVSNovartis AG ADRAZNAstraZeneca PLCNVONovo Nordisk A/STMOThermo Fisher Scientific IncAMGNAmgen IncABTAbbott LaboratoriesGILDGilead Sciences Inc
View all HEALTHCARE stocks →
Data last updated: 7/29/2026